Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irvin Xu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Coronary Artery Disease|April 7, 2021
Baseline testosterone level may modulate statin efficacyIrvin Xu, Pam R Taub
Journal of Diabetes Research|April 3, 2019
A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human <i>β</i>-Cell Replication and Survival as well as GABA's Ability to Inhibit Inflammatory T CellsJide Tian, Hoa Dang, Nataliya Karashchuk, et al.
American Journal of Preventive Cardiology|March 3, 2023
Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery diseaseMichael J Wilkinson, Irvin Xu, Rajiv S Vasudevan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Coronary Artery Disease|April 7, 2021
Baseline testosterone level may modulate statin efficacyIrvin Xu, Pam R Taub
Journal of Diabetes Research|April 3, 2019
A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human <i>β</i>-Cell Replication and Survival as well as GABA's Ability to Inhibit Inflammatory T CellsJide Tian, Hoa Dang, Nataliya Karashchuk, et al.
American Journal of Preventive Cardiology|March 3, 2023
Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery diseaseMichael J Wilkinson, Irvin Xu, Rajiv S Vasudevan, et al.
Pageof 1